DYN vs PPL · $1.19B cap vs P/E 22, rev $8.46B
Dyne Therapeutics Inc (DYN) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
DYN does not have a complete income-statement cache yet.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
DYN currently screens at market cap $1.19B. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the DYN and PPL stock pages for the full models.
Not investment advice.